Coupling Genome Defence to Epigenetic Reprogramming
News Sep 06, 2012
The promoters of these genes appear to possess a specialised chromatin environment that does not acquire any of the repressive H3K27me3, H3K9me2, H3K9me3 or H4K20me3 histone modifications when silenced by DNA methylation in somatic cells. Intriguingly, this methylation-dependent subset is highly enriched in genes with roles in suppressing Transposable element activity in germ cells.
DNA methylation plays an important role in gene silencing and repressing
transposable elements (TEs). During primordial germ
cell (PGC) development, DNA methylation marks are
erased during extensive epigenetic reprogramming, so how does this
impact gene expression and TE repression in PGCs?
Richard Meehan and co-workers
show that DNA methylation at the promoters of germline-specific genes
couples genome-defence mechanisms to epigenetic reprogramming
in mouse PGCs. The researchers identify a set of
germline-specific genes that are dependent exclusively on promoter DNA
for their silencing; their promoters possess
specialised chromatin in somatic cells that does not acquire additional
histone modifications. This set, they discover, is
enriched in genes involved in suppressing TE activity in germ cells, and
the expression of these genes is activated during two
phases of DNA demethylation in PGCs. These findings suggest that unique
reliance on promoter DNA methylation acts as a highly
tuned sensor of global DNA demethylation and allows PGCs to be primed
to suppress TEs.
Hackett JA, Reddington JP, Nestor CE, Dunican DS, Branco MR, Reichmann J, Reik W, Surani MA, Adams IR, Meehan RR.
Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline.
Development. 2012 Oct;139(19):3623-32. PubMed PMID: 22949617.
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Comments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.Cancer Research Cell Science Diagnostics Genomics Research Informatics & Automation Proteomics & Metabolomics
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018